Evidence map›Paper›PMID 23180869›Full record

ArticleGut2014

Genome-wide association study of survival in patients with pancreatic adenocarcinoma.

Chen Wu, Peter Kraft, Rachael Stolzenberg-Solomon, Emily Steplowski, Michelle Brotzman, Mousheng Xu, Poorva Mudgal, Laufey Amundadottir, Alan A Arslan, H Bas Bueno-de-Mesquita and 46 more

Abstract read
In one paragraph

Article in Gut, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Do Polygenic Risk Scores Add to Clinical Data in Predicting Pancreatic Cancer? A Scoping Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors.

Chen WuDepartment of Epidemiology, Harvard School of Public Health, , Boston, Massachusetts, USA.
Peter Kraft
Rachael Stolzenberg-Solomon
Emily Steplowski
Michelle Brotzman
Mousheng Xu
Poorva Mudgal
Laufey Amundadottir
Alan A Arslan
H Bas Bueno-de-Mesquita
Myron Gross
Kathy Helzlsouer
Eric J Jacobs
Charles Kooperberg
Gloria M Petersen
Wei Zheng
Demetrius Albanes
Marie-Christine Boutron-Ruault
Julie E Buring
Federico Canzian
Guangwen Cao
Eric J Duell
Joanne W Elena
J Michael Gaziano
Edward L Giovannucci
Goran Hallmans
Amy Hutchinson
David J Hunter
Mazda Jenab
Guoliang Jiang
Kay-Tee Khaw
Andrea LaCroix
Zhaoshen Li
Julie B Mendelsohn
Salvatore Panico
Alpa V Patel
Zhi Rong Qian
Elio Riboli
Howard Sesso
Hongbing Shen
Xiao-Ou Shu
Anne Tjonneland
Geoffrey S Tobias
Dimitrios Trichopoulos
Jarmo Virtamo
Kala Visvanathan
Jean Wactawski-Wende
Chengfeng Wang
Kai Yu
Anne Zeleniuch-Jacquotte
Stephen Chanock
Robert Hoover
Patricia Hartge
Charles S Fuchs
Dongxin Lin
Brian M Wolpin

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WILLETT, WALTER C. · 1991 to 2009
$41.8M
Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI EL-BARDEESY, NABEEL, SELLERS, WILLIAM R · 2007 to 2023
$33.2M
Women's Health Study: Continued Follow-upR01CA047988 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., LEE, I-MIN · 1991 to 2014
$28.2M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
Physicians' Health Study II: Prevention Trial of VitaminsR01CA097193 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI GAZIANO, J. MICHAEL · 2002 to 2011
$15.7M
Vitamin D, Related Genes and Breast Cancer RiskR01CA098661 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELENIUCH-JAQUOTTE, ANNE · 2003 to 2013
$9.7M
Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan)ZIACP010193 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI STOLZENBERG-SOLOMON, RACHAEL · 2009 to 2025
$9.5M
Cohort Study of Cancer inhibitory Factors in MenR01CA082729 · NCI · VANDERBILT UNIVERSITY · PI SHU, XIAO-OU · 2001 to 2011
$6.3M
Cancer Research UK 14136CCR NIH HHS HHSN261200800001CCCR NIH HHS N01 RC037004Howard Hughes Medical InstituteIntramural NIH HHSMedical Research Council G0401527Medical Research Council G1000143NCI NIH HHS CA105069NCI NIH HHS CA 34944NCI NIH HHS CA 40360NCI NIH HHS CA73790NCI NIH HHS CA 97193NCI NIH HHS HHSN261200800001ENCI NIH HHS HHSN261201000006CNCI NIH HHS K07 CA140790NCI NIH HHS L30 CA130644NCI NIH HHS N01 CN045165NCI NIH HHS NCI K07 CA140790NCI NIH HHS P01 CA055075NCI NIH HHS P01 CA087969NCI NIH HHS P01 CA55075NCI NIH HHS P01 CA87969NCI NIH HHS P30 CA015083NCI NIH HHS P30 CA015704NCI NIH HHS P30 CA016087NCI NIH HHS P30CA016087NCI NIH HHS P50 CA127003NCI NIH HHS R01CA034588NCI NIH HHS R01 CA034944NCI NIH HHS R01 CA040360NCI NIH HHS R01 CA047988NCI NIH HHS R01 CA082729NCI NIH HHS R01 CA097193NCI NIH HHS R01 CA098661NCI NIH HHS R01CA098661NCI NIH HHS R01 CA105069NCI NIH HHS R01 CA124908NCI NIH HHS R01 CA82729NCI NIH HHS R37 CA070867NCI NIH HHS R37 CA70867NCI NIH HHS UM1 CA173640NCI NIH HHS UM1 CA182910NHLBI NIH HHS HL 26490NHLBI NIH HHS HL 34595NHLBI NIH HHS R01 HL026490NHLBI NIH HHS R01 HL034595NIA NIH HHS 5U01AG018033NIA NIH HHS U01 AG018033NIEHS NIH HHS ES000260NIEHS NIH HHS P30 ES000260WHI NIH HHS N01 WH022110
6 · The paper itself

Abstract

BACKGROUND AND

objectiveSurvival of patients with pancreatic adenocarcinoma is limited and few prognostic factors are known. We conducted a two-stage genome-wide association study (GWAS) to identify germline variants associated with survival in patients with pancreatic adenocarcinoma.

methodsWe analysed overall survival in relation to single nucleotide polymorphisms (SNPs) among 1005 patients from two large GWAS datasets, PanScan I and ChinaPC. Cox proportional hazards regression was used in an additive genetic model with adjustment for age, sex, clinical stage and the top four principal components of population stratification. The first stage included 642 cases of European ancestry (PanScan), from which the top SNPs (p≤10(-5)) were advanced to a joint analysis with 363 additional patients from China (ChinaPC).

resultsIn the first stage of cases of European descent, the top-ranked loci were at chromosomes 11p15.4, 18p11.21 and 1p36.13, tagged by rs12362504 (p=1.63×10(-7)), rs981621 (p=1.65×10(-7)) and rs16861827 (p=3.75×10(-7)), respectively. 131 SNPs with p≤10(-5) were advanced to a joint analysis with cases from the ChinaPC study. In the joint analysis, the top-ranked SNP was rs10500715 (minor allele frequency, 0.37; p=1.72×10(-7)) on chromosome 11p15.4, which is intronic to the SET binding factor 2 (SBF2) gene. The HR (95% CI) for death was 0.74 (0.66 to 0.84) in PanScan I, 0.79 (0.65 to 0.97) in ChinaPC and 0.76 (0.68 to 0.84) in the joint analysis.

conclusionsGermline genetic variation in the SBF2 locus was associated with overall survival in patients with pancreatic adenocarcinoma of European and Asian ancestry. This association should be investigated in additional large patient cohorts.

Indexed as

Genome-Wide Association StudyPolymorphism, Single NucleotideAdenocarcinomaAdultAgedAged, 80 and overAsian PeopleBiomarkers, TumorChinaEuropeFemaleFollow-Up StudiesHumansKaplan-Meier EstimateMaleMiddle AgedBiomarkers, TumorProtein Tyrosine Phosphatases, Non-ReceptorSBF2 protein, humanCancer GeneticsMolecular EpidemiologyPancreatic Cancer

Identifiers

PMID23180869
PMCPMC3816124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.